Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Krebs Biochemicals & Industries Ltd. ( (IN:KREBSBIO) ) just unveiled an update.
Krebs Biochemicals & Industries Ltd. has announced that, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015, it will close its trading window for dealings in its securities from the close of business on 31 December 2025 until 48 hours after the declaration of its unaudited financial results for the third quarter and nine months ended 31 December 2025. The restriction applies to promoters, directors, designated persons, their immediate relatives and other connected parties, and signals the company’s preparation for its upcoming financial disclosure, with the exact date of the board meeting to consider these results to be communicated to the exchanges in due course.
More about Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries Ltd. is an India-based company in the biochemicals and pharmaceutical ingredients space, with its registered office in Andhra Pradesh and equity shares listed on both BSE and the National Stock Exchange under the scrip code KREBSBIO.
Average Trading Volume: 3,435
Technical Sentiment Signal: Sell
Current Market Cap: 1.51B INR
Find detailed analytics on KREBSBIO stock on TipRanks’ Stock Analysis page.